Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05525767 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

StatusRecruiting
PhasePhase 4
Started2022-03-31
View on ClinicalTrials.gov ↗

Amendment history

2025-12-04
Study Status v1
Primary completion date2024-10-31→2026-10-31
Completion date2025-12-31→2028-12-31
2022-08-31
Original filing
This is an prospective, multicenter, single-arm clinical study.
Trial Details
NCT Number NCT05525767
Lead Sponsor Hebei Medical University Fourth Hospital
Conditions Solid Tumor
Enrollment 75 participants
Start Date 2022-03-31
Primary Completion 2026-10-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-11